A Study To Assess The Feasibility Of Indivi Mobile Application In Monitoring Cognitive Performance In Aging Population

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Indivi AG
Study ID
NCT07174869
Status
Recruiting

Conditions

  • Mild Alzheimer Disease
  • Mild Cognitive Impairment (MCI)

Eligibility Criteria

Sex
ALL
Age
50 Years - 90 Years
Healthy Volunteers
Accepted

Study Details

The goal of this observational study is to evaluate the functionality and usability of Indivi mobile application-based cognitive activities in people with mild cognitive impairment/mild Alzheimer's disease (PwMCI/AD) and healthy controls (HC). This application uses a dynamic difficulty adjustment (DDA) system that customizes the level of the cognitive activities to each user. The main questions it aims to answer are: * Does the DDA system reach a stable difficulty level at the same rate for both PwMCI/AD and HC? * Is the stable difficulty level reached by the DDA system different for PwMCI/AD compared to HC? Researchers will also compare cognitive activities results and other aspects of the mobile application's performance to see if the application can validly distinguish between the two groups. Participants will use the Indivi mobile application, with its embedded DDA system, for a 6-week period.

Key Dates

Start date
Sep 30, 2025
Status verified
Sep 2025
Primary completion
Jun 30, 2026
Completion
Jun 30, 2026

Study Design

Enrollment
55 participants (estimated)

Arms

  • Arm: PwMCI/AD
    Persons with Mild Cognitive Impairment or mild Alzheimer's Disease
  • Arm: HC
    Healthy Controls

Primary Outcome Measure

Number of test iterations until stable difficulty level is reached [ Time Frame: During the 6-week study period. ]

Locations (1)

FacilityCityStateZIPSite coordinators
Boston University School of MedicineBostonMassachusetts02118
Burk, Alexa
617-358-1959

Find similar trials in Boston, MA

Related Studies